The role of microRNAs in the resistance to colorectal cancer treatments

Cellular and Molecular Biology

Volumn 61, Issue 6, 2015, Pages 17-23

  Amirkhah, R ^a   Farazmand, Ali ^a   Irfan Maqsood, M ^b   Wolkenhauer, O ^c,d   Schmitz, U ^c,e,f  

^a UNIVERSITY OF TEHRAN   (Iran)

^b FERDOWSI UNIVERSITY OF MASHHAD   (Iran)

^c UNIVERSITY OF ROSTOCK   (Germany)

^d STELLENBOSCH UNIVERSITY   (South Africa)

^e CENTENARY INSTITUTE   (Australia)

^f UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Biomarker; Chemotherapy; Colorectal cancer; MicroRNA; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; FLUOROURACIL; MICRORNA; MICRORNA 34A; SIRTUIN 1; TRANSCRIPTION FACTOR E2F3; TUMOR MARKER;

ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER RESISTANCE; CANCER THERAPY; CHEMOSENSITIVITY; COLORECTAL CANCER; DNA DAMAGE; DOWN REGULATION; GENE OVEREXPRESSION; HUMAN; METASTASIS INHIBITION; MOLECULARLY TARGETED THERAPY; TREATMENT RESPONSE; ANTAGONISTS AND INHIBITORS; COLORECTAL NEOPLASMS; DRUG RESISTANCE; METABOLISM; SIGNAL TRANSDUCTION;

BIOMARKERS, TUMOR; COLORECTAL NEOPLASMS; DNA DAMAGE; DRUG RESISTANCE, NEOPLASM; HUMANS; MICRORNAS; SIGNAL TRANSDUCTION;

EID: 84962147369     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: 10.14715/cmb/2015.61.6.4     Document Type: Article

References (62)

1. Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E., Forman, D., Global cancer statistics. CA: a cancer journal for clinicians. 2011;61(2):69-90, doi: 10.3322/caac.20107.
2. Kurkjian, C., Kummar, S., Advances in the treatment of metastatic colorectal cancer. American journal of therapeutics. 2009;16(5):412-20, doi: 10.1097/MJT.0b013e3181907ed9.
3. Fang, L., Li, H., Wang, L., Hu, J., Jin, T., Wang, J., et al. MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression. Oncotarget. 2014;5(10):2974-87.
4. Yu, H.W., Cho, W.C., The emerging role of miRNAs in combined cancer therapy. Expert opinion on biological therapy. 2015:1-3, doi: 10.1517/14712598.2015.1030390.
5. Amirkhah, R., Schmitz, U., Linnebacher, M., Wolkenhauer, O., Farazmand, A. MicroRNA-mRNA interactions in colorectal cancer and their role in tumor progression. Genes, chromosomes & cancer. 2015;54(3):129-41, doi: 10.1002/gcc.22231.
6. Jiang, Q., Wang, Y., Hao, Y., Juan, L., Teng, M., Zhang, X., et al. miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic acids research. 2009;37(Database issue):D98-104, doi: 10.1093/nar/gkn714.
7. Bushati, N., Cohen, SM. microRNA functions. Annual review of cell and developmental biology. 2007;23:175-205, doi: 10.1146/annurev.cellbio.23.090506.123406.
8. Calin, G.A., Croce, C.M. MicroRNA signatures in human cancers. Nature reviews Cancer. 2006;6(11):857-66, doi: 10.1038/nrc1997.
9. Schmitz, U., Wolkenhauer, O., Vera, J. MicroRNA Cancer Regulation Advanced Concepts, Bioinformatics and Systems Biology Tools. Dordrecht: Springer; 2013.
10. MacDonagh, L., Gray, S.G., Finn, S.P., Cuffe, S., O'Byrne, K.J., Barr, M.P., The emerging role of microRNAs in resistance to lung cancer treatments. Cancer treatment reviews. 2015;41(2):160-9, doi: 10.1016/j.ctrv.2014.12.009.
11. Stahlhut, C., Slack, F.J. MicroRNAs and the cancer phenotype: profiling, signatures and clinical implications. Genome medicine. 2013;5(12):111, doi: 10.1186/gm516.
12. Alymani, N.A., Smith, M.D., Williams, D.J., Petty, R.D., Predictive biomarkers for personalised anti-cancer drug use: discovery to clinical implementation. European journal of cancer (Oxford, England: 1990). 2010;46(5):869-79, doi: 10.1016/j.ejca.2010.01.001.
13. Wang, Z., Li, Y., Ahmad, A., Azmi, A.S., Banerjee, S., Kong, D., et al., Targeting Notch signaling pathway to overcome drug resistance for cancer therapy. Biochimica et biophysica acta. 2010;1806(2):258-67, doi: 10.1016/j.bbcan.2010.06.001.
14. Nita, M.E., Nagawa, H., Tominaga, O., Tsuno, N., Fujii, S., Sasaki, S., et al. 5-Fluorouracil induces apoptosis in human colon cancer cell lines with modulation of Bcl-2 family proteins. British journal of cancer. 1998;78(8):986-92.
15. Zhang, H., Tang, J., Li, C., Kong, J., Wang, J., Wu, Y., et al. MiR-22 regulates 5-FU sensitivity by inhibiting autophagy and promoting apoptosis in colorectal cancer cells. Cancer letters. 2015;356(2 Pt B):781-90, doi: 10.1016/j.canlet.2014.10.029.
16. Borralho, P.M., Kren, B.T., Castro, R.E., da Silva, I.B., Steer, C.J., Rodrigues, C.M. MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells. The FEBS journal. 2009;276(22):6689-700, doi: 10.1111/j.1742-4658.2009.07383.x.
17. Marani, M., Tenev, T., Hancock, D., Downward, J., Lemoine, N.R., Identification of novel isoforms of the BH3 domain protein Bim which directly activate Bax to trigger apoptosis. Molecular and cellular biology. 2002;22(11):3577-89.
18. Czabotar, P.E., Colman, P.M., Huang, D.C., Bax activation by Bim? Cell death and differentiation. 2009;16(9):1187-91, doi: 10.1038/cdd.2009.83.
19. Nishida, N., Yamashita, S., Mimori, K., Sudo, T., Tanaka, F., Shibata, K., et al. MicroRNA-10b is a prognostic indicator in colorectal cancer and confers resistance to the chemotherapeutic agent 5-fluorouracil in colorectal cancer cells. Annals of surgical oncology. 2012;19(9):3065-71, doi: 10.1245/s10434-012-2246-1.
20. Kim, S.A., Kim, I., Yoon, S.K., Lee, E.K., Kuh, H.J., Indirect modulation of sensitivity to 5-fluorouracil by microRNA-96 in human colorectal cancer cells. Archives of pharmacal research. 2015;38(2):239-48, doi: 10.1007/s12272-014-0528-9.
21. Karaayvaz, M., Zhai, H., Ju, J. miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer. Cell death & disease. 2013;4:e659, doi: 10.1038/cddis.2013.193.
22. Akao, Y., Noguchi, S., Iio, A., Kojima, K., Takagi, T., Naoe, T., Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells. Cancer letters. 2011;300(2):197-204, doi: 10.1016/j.canlet.2010.10.006.
23. Martinez, L.A., Goluszko, E., Chen, H.Z., Leone, G., Post, S., Lozano, G., et al. E2F3 is a mediator of DNA damage-induced apoptosis. Molecular and cellular biology. 2010;30(2):524-36, doi: 10.1128/mcb.00938-09.
24. Yamakuchi, M., Ferlito, M., Lowenstein, C.J. miR-34a repression of SIRT1 regulates apoptosis. Proceedings of the National Academy of Sciences of the United States of America. 2008;105(36):13421-6, doi: 10.1073/pnas.0801613105.
25. Valeri, N., Gasparini, P., Braconi, C., Paone, A., Lovat, F., Fabbri, M., et al. MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2). Proceedings of the National Academy of Sciences of the United States of America. 2010;107(49):21098-103, doi: 10.1073/pnas.1015541107.
26. Longley, DB., Harkin, D.P., Johnston, P.G. 5-fluorouracil: mechanisms of action and clinical strategies. Nature reviews Cancer. 2003;3(5):330-8, doi: 10.1038/nrc1074.
27. Pabla, N., Ma, Z., McIlhatton, M.A., Fishel, R., Dong, Z. hMSH2 recruits ATR to DNA damage sites for activation during DNA damage-induced apoptosis. The Journal of biological chemistry. 2011;286(12):10411-8, doi: 10.1074/jbc.M110.210989.
28. Deng, J., Lei, W., Fu, J.C., Zhang, L., Li, J.H., Xiong, J.P., Targeting miR-21 enhances the sensitivity of human colon cancer HT-29 cells to chemoradiotherapy in vitro. Biochem Biophys Res Commun. 2014;443(3):789-95, doi: 10.1016/j.bbrc.2013.11.064.
29. Zhou, Y., Wan, G., Spizzo, R., Ivan, C., Mathur, R., Hu, X., et al. miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase. Molecular oncology. 2014;8(1):83-92, doi: 10.1016/j.molonc.2013.09.004.
30. Qian, X., Yu, J., Yin, Y., He, J., Wang, L., Li, Q., et al. MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers. Cell cycle (Georgetown, Tex). 2013;12(9):1385-94, doi: 10.4161/cc.24477.
31. Xiong, L., Kou, F., Yang, Y., Wu, J., A novel role for IGF-1R in p53-mediated apoptosis through translational modulation of the p53-Mdm2 feedback loop. The Journal of cell biology. 2007;178(6):995-1007, doi: 10.1083/jcb.200703044.
32. Zhang, Y., Geng, L., Talmon, G., Wang, J. MicroRNA-520g confers drug resistance by regulating p21 expression in colorectal cancer. The Journal of biological chemistry. 2015;290(10):6215-25, doi: 10.1074/jbc.M114.620252.
33. Liao, Q., Xiao, H., Bu, D., Xie, C., Miao, R., Luo, H., et al. ncFANs: a web server for functional annotation of long non-coding RNAs. Nucleic Acids Res. 2011;39:W118-24, doi: 10.1093/nar/gkr432 10.1093/nar/gkr432..
34. Li, J., Zhang, Y., Zhao, J., Kong, F., Chen, Y., Overexpression of miR-22 reverses paclitaxel-induced chemoresistance through activation of PTEN signaling in p53-mutated colon cancer cells. Molecular and cellular biochemistry. 2011;357(1-2):31-8, doi: 10.1007/s11010-011-0872-8.
35. Li, J., Chen, Y., Zhao, J., Kong, F., Zhang, Y. miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression. Cancer letters. 2011;304(1):52-9, doi: 10.1016/j.canlet.2011.02.003.
36. Xu, K., Liang, X., Shen, K., Cui, D., Zheng, Y., Xu, J., et al. miR-297 modulates multidrug resistance in human colorectal carcinoma by down-regulating MRP-2. The Biochemical journal. 2012;446(2):291-300, doi: 10.1042/bj20120386.
37. Glavinas, H., Krajcsi, P., Cserepes, J., Sarkadi, B., The role of ABC transporters in drug resistance, metabolism and toxicity. Current drug delivery. 2004;1(1):27-42.
38. Xu, K., Liang, X., Cui, D., Wu, Y., Shi, W., Liu, J. miR-1915 inhibits Bcl-2 to modulate multidrug resistance by increasing drug-sensitivity in human colorectal carcinoma cells. Molecular carcinogenesis. 2013;52(1):70-8, doi: 10.1002/mc.21832.
39. Nakazawa, K., Dashzeveg, N., Yoshida, K., Tumor suppressor p53 induces miR-1915 processing to inhibit Bcl-2 in the apoptotic response to DNA damage. The FEBS journal. 2014;281(13):2937-44, doi: 10.1111/febs.12831.
40. Zhang, Y., Zheng, L., Huang, J., Gao, F., Lin, X., He, L., et al. MiR-124 Radiosensitizes human colorectal cancer cells by targeting PRRX1. PLOS ONE. 2014;9(4):e93917, doi: 10.1371/journal.pone.0093917.
41. Ma, W., Yu, J., Qi, X., Liang, L., Zhang, Y., Ding, Y., et al. Radiation-induced MicroRNA-622 causes radioresistance in colorectal cancer cells by down-regulating Rb. Oncotarget; Advance Online Publications: Page 2. 2015.
42. Yang, X.D., Xu, X.H., Zhang, S.Y., Wu, Y., Xing, C.G., Ru, G., et al., Role of miR-100 in the radioresistance of colorectal cancer cells. Am J Cancer Res. 2015;5(2):545-59.
43. Pritchard, C.C., Grady, W.M., Colorectal cancer molecular biology moves into clinical practice. Gut. 2011;60(1):116-29, doi: 10.1136/gut.2009.206250.
44. Migliore, C., Giordano, S., Resistance to targeted therapies: a role for microRNAs? Trends in molecular medicine. 2013;19(10):633-42, doi: 10.1016/j.molmed.2013.08.002.
45. Mlcochova, J., Faltejskova, P., Nemecek, R., Svoboda, M., Slaby, O. MicroRNAs targeting EGFR signalling pathway in colorectal cancer. Journal of cancer research and clinical oncology. 2013;139(10):1615-24, doi: 10.1007/s00432-013-1470-9.
46. Suto, T., Yokobori, T., Yajima, R., Morita, H., Fujii, T., Yamaguchi, S., et al. MicroRNA-7 expression in colorectal cancer is associated with poor prognosis and regulates cetuximab sensitivity via EGFR regulation. Carcinogenesis. 2015;36(3):338-45, doi: 10.1093/carcin/bgu242.
47. Supek, F., Bošnjak, M., Škunca, N., Šmuc, T., RE VIGO summarizes and visualizes long lists of gene ontology terms. PloS one. 2011;6(7):e21800.
48. Allen, K.E., Weiss, G.J., Resistance may not be futile: microRNA biomarkers for chemoresistance and potential therapeutics. Molecular cancer therapeutics. 2010;9(12):3126-36, doi: 10.1158/1535-7163.mct-10-0397.
49. Zheng, T., Wang, J., Chen, X., Liu, L., Role of microRNA in anticancer drug resistance. International journal of cancer Journal international du cancer. 2010;126(1):2-10, doi: 10.1002/ijc.24782.
50. Qu, J., Zhao, L., Zhang, P., Wang, J., Xu, N., Mi, W., et al. MicroRNA-195 chemosensitizes colon cancer cells to the chemotherapeutic drug doxorubicin by targeting the first binding site of BCL2L2 mRNA. Journal of cellular physiology. 2015;230(3):535-45, doi: 10.1002/jcp.24366.
51. Li, Y., Ahmad, A., Sarkar and F. H., ASPP and iASPP: Implication in cancer development and progression. Cell. Mol. Biol. 2015, 61(6): 2-8.
52. Masood, N., Qureshi, M. Z. and Yasmin, A., Association of NOTCH with different microRNAs in head and neck cancer. Cell. Mol. Biol. 2015, 61(6): 9-16.
53. Wang, Z., Chen, J. and Capobianco, A. J., The Notch signaling pathway in esophageal adenocarcinoma. Cell. Mol. Biol. 2015, 61(6): 24-32.
54. Limami, Y., Pinon, A., Riaz, A. and Simon, A., TRAIL and targeting cancer cells: between promises and obstacles. Cell. Mol. Biol. 2015, 61(6): 33-38.
55. Silva Galbiatti-Dias, A. L., Pavarino, É. C., Kawasaki-Oyama, R. S., Maniglia, J. V., Maniglia, E. J. V. and Goloni Bertollo, E. M., Cancer stem cells in head and neck cancer: A Mini Review. Cell. Mol. Biol. 2015, 61(6): 39-43.
56. Musella, A., Marchetti, C., Gasparri, M. L., Salerno, L., Casorelli, A., Domenici, L., Imperiale, L., Ruscito, I., Abdul Halim, T., Palaia, I., Di Donato, V., Pecorini, F., Monti, M., Muzii, L. and Panici, P. B., PARP inhibition: A promising therapeutic target in ovarian cancer. Cell. Mol. Biol. 2015, 61(6): 44-61.
57. Attar, R., Tabassum, S., Fayyaz, S., Ahmad, M. S., Nogueira, D. R., Yaylim, I., Timirci-Kahraman, O., Kucukhuseyin, O., Cacina, C., Farooqi, A. A. and Ismail, M., Natural products are the future of anticancer therapy: Preclinical and clinical advancements of Viscum album phytometabolites. Cell. Mol. Biol. 2015, 61(6): 62-68.
58. Hsu, Y-C., Hsieh, Y-H., Liao, C-C., Chong, L-W., Lee, C-Y., Yu, Y-L. and Chou, R-H., Targeting post-translational modifications of histones for cancer therapy. Cell. Mol. Biol. 2015, 61(6): 69-84.
59. Chong, L-W., Chou, R-H., Liao, C-C., Lee, T-F., Lin, Y., Yang, K-C. and Hsu, Y-C., Saturated fatty acid induces cancer stem cell-like properties in human hepatoma cells. Cell. Mol. Biol. 2015, 61(6): 85-91.
60. Smina, T. P., Mohan, A., Ayyappa, K. A., Sethuraman, S. and Krishnan, U. M., Hesperetin exerts apoptotic effect on A431 skin carcinoma cells by regulating mitogen activated protein kinases and cyclins. Cell. Mol. Biol. 2015, 61(6): 92-99.
61. Ahmadi, M., Jafari, R., Marashi, S. A. and Farazmand, A., Indirect role of microRNAs and transcription factors in the regulation of important cancer genes: A network biology approach. Cell. Mol. Biol. 2015, 61(6): 100-107.
62. Zahoor, A., Mansoor, Q., Farooqi, A. A., Fayyaz, S., Naz, G. and Ismail, M., Genetic variants in the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and death receptor (DR4) genes contribute to susceptibility to colorectal cancer in pakistani population. Cell. Mol. Biol. 2015, 61(6): 108-112.